Showing results (1-10 of 688) with videos related to
Sort By:
Pageof 69
Journal of Hematotherapy|August 1, 1996
Allogeneic peripheral blood progenitor cells: current status and future directionsP Dreger, B Glass, L Uharek, et al.International Journal of Hematology|July 1, 1997
Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapyP Dreger, B Glass, L Uharek, et al.Blood|August 15, 1997
Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effectB Glass, L Uharek, M Zeis, et al.Experimental Hematology|February 24, 1998
Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT)L Uharek, B Glass, M Zeis, et al.British Journal of Haematology|March 1, 1997
Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in miceM Zeis, L Uharek, B Glass, et al.Experimental Hematology|October 10, 1998
Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantationM Zeis, L Uharek, B Glass, et al.Bone Marrow Transplantation|June 20, 2003
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation modelG Hartung, M Zeis, B Glass, et al.Bone Marrow Transplantation|August 26, 1998
Immunotherapeutic aspects of allogeneic peripheral progenitor cellsB Glass, L Uharek, G Hartung, et al.Bone Marrow Transplantation|August 26, 1998
Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF aloneG Hartung, L Uharek, M Zeis, et al.Leukemia|November 1, 1996
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2L Uharek, M Zeis, B Glass, et al.Pageof 69